Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 3/20 | 0.31 |
| ▸ | MMP3 | P08254 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1128377 | 0.90 | MAOA (0.36) | MAOAMAOBHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL9160477 | 0.85 | MAOA (0.39) | MAOAMAOBHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL10476775 | 0.85 | MAOA (0.39) | MAOAMAOBHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL36333 | 0.85 | MAOA (0.39) | MAOAMAOBHPGDALDH1A1SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL1871983 | 0.83 | MAOA (0.37) | MAOAMAOBHPGDALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL585839 | 0.83 | MAOA (0.37) | MAOAMAOBHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL1128512 | 0.82 | — | — | |
| Ethylene SCHEMBL9721427 | 0.81 | MAOA (0.36) | MAOAMAOBHSD17B10HTR2C | |
| Bicarbonate SCHEMBL8096283 | 0.80 | SRD5A2 (0.38) | MAOAMAOBALDH1A1MAPTHSD17B10 | |
| Trimethylammonium SCHEMBL10477929 | 0.78 | HTR2A (0.37) | MAOAMAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101952269-B | Sulphonium salt initiators | BASF SE | 2014-06-25 | — | — | CN | disclosed |
| US-8652752-B2 | Sulphonium salt initiators | BASF SE (DE) | 2014-02-18 | — | — | US | disclosed |
| EP-2197869-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-04-24 | — | — | EP | disclosed |
| CN-101522613-B | Sulphonium salt photoinitiators | CIBA HOLDING INC | 2013-03-06 | — | — | CN | disclosed |
| EP-2197839-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-01-02 | — | — | EP | disclosed |
| EP-2125713-B1 | SULPHONIUM SALT PHOTOINITIATORS | BASF SE (DE) | 2012-04-18 | — | — | EP | disclosed |
| US-8012672-B2 | Sulphonium salt photoinitiators | BASF SE (DE) | 2011-09-06 | — | — | US | disclosed |
| CN-101952269-A | Sulphonium salt initiators | BASF SE | 2011-01-19 | — | — | CN | disclosed |
| US-20100297541-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100297540-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-11-25 | — | — | US | disclosed |
| EP-2197839-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-06-23 | — | — | EP | disclosed |
| EP-2197869-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-06-23 | — | — | EP | disclosed |
| US-20100087563-A1 | SULPHONIUM SALT PHOTOINITIATORS | BASF SE (DE) | 2010-04-08 | — | — | US | disclosed |
| EP-2125713-A1 | SULPHONIUM SALT PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2009-12-02 | — | — | EP | disclosed |
| CN-101522613-A | Sulphonium salt photoinitiators | CIBA SC HOLDING AG (CH) | 2009-09-02 | — | — | CN | disclosed |
| WO-2009047152-A1 | SULPHONIUM SALT INITIATORS | BASF SE (CH) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009047105-A1 | SULPHONIUM SALT INITIATORS | BASF SE (CH) | 2009-04-16 | — | — | WO | disclosed |
| WO-2008040648-A1 | SULPHONIUM SALT PHOTOINITIATORS | CIBA HOLDING INC. (CH) | 2008-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087563-A1 | SULPHONIUM SALT PHOTOINITIATORS | SULT1A1, NCOR1, ARSA | MAOA 1253/4885MAOB 2187/4885HPGD 2449/4885 |
| US-20100297540-A1 | SULPHONIUM SALT INITIATORS | SULT1A1, SULT2A1, NCOA1 | MAOA 2820/4885MAOB 4087/4885HPGD 3606/4885 |
| US-20100297541-A1 | SULPHONIUM SALT INITIATORS | NCOR1, NCOR2, SMARCC2 | MAOA 4545/4885MAOB 3581/4885HPGD 4440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.